Skip to content

SNY

Sanofi

NASDAQ · Healthcare · Drug Manufacturers - General · FR

$39.57
−2.56%
Ask drillr

Year over year

Reported trailing growth

Revenue
+13.4%
EBITDA
+36.2%
EBIT
-8.6%
EPS
-87.5%
Free cash flow
+462.3%
Operating cash flow
+582.9%

Forward estimates

Based on analyst estimates

Revenue
-74.7%
EBITDA
-63.7%
EPS
+91.9%

Three-year CAGR

Revenue
+4.8%
EBITDA
-2.6%
EBIT
-1.9%
Net income
-2.3%
EPS
+0.1%
Free cash flow
+6.4%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026